应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRK 默沙东
耶稣受难日休市 03-28 16:00:00 EDT
131.95
+0.20
+0.15%
盘后
131.95
+0.00
0.00%
19:57 EDT
最高
132.42
最低
131.08
成交量
1,019万
今开
132.00
昨收
131.75
日振幅
1.02%
总市值
3,342亿
流通市值
3,335亿
总股本
25.33亿
成交额
13.43亿
换手率
0.40%
流通股本
25.28亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
重磅新药获批 默沙东股价再创历史新高丨从华尔街到陆家嘴
第一财经 · 03-29 10:31
重磅新药获批 默沙东股价再创历史新高丨从华尔街到陆家嘴
默沙东甲肝疫苗即将退出中国
健识局 · 03-28 20:56
默沙东甲肝疫苗即将退出中国
默沙东重磅新药在美获批 定价14000美元
国际金融报 · 03-28 20:14
默沙东重磅新药在美获批 定价14000美元
重磅新药获批,1瓶10万!股价狂飙,影响多大?
券商中国 · 03-28 09:10
重磅新药获批,1瓶10万!股价狂飙,影响多大?
隔夜美股全复盘(3.28)| 三大股指集体收涨,DJT涨逾14%,华尔街对特朗普科技集团估值达到110亿预期
格隆汇 · 03-28 07:39
隔夜美股全复盘(3.28)| 三大股指集体收涨,DJT涨逾14%,华尔街对特朗普科技集团估值达到110亿预期
美股三大指数集体高开 默沙东涨近6%
证券时报e公司 · 03-27 21:35
美股三大指数集体高开 默沙东涨近6%
默沙东盘中异动 股价大涨5.85%
自选股智能写手 · 03-27 21:34
默沙东盘中异动 股价大涨5.85%
国产九价HPV疫苗有望今年上市 市场格局或生变
新京报网 · 03-27 21:34
国产九价HPV疫苗有望今年上市 市场格局或生变
《美国股市》道指早段飙逾300点跑出 默克新药获批股价飙5% 英伟达逆市跌
阿斯达克财经 · 03-27 21:31
《美国股市》道指早段飙逾300点跑出 默克新药获批股价飙5% 英伟达逆市跌
默沙东进口甲肝疫苗将退出国内市场
南方财经网 · 03-27 18:06
默沙东进口甲肝疫苗将退出国内市场
BUZZ-默克公司因美国食品药品管理局批准罕见肺病疗法而上涨
Reuters · 03-27 17:55
BUZZ-默克公司因美国食品药品管理局批准罕见肺病疗法而上涨
默沙东盘前涨超4%势创新高 肺动脉高压药物sotatercept获FDA批准
金融界 · 03-27 16:17
默沙东盘前涨超4%势创新高 肺动脉高压药物sotatercept获FDA批准
默沙东去年打款超14亿元 科伦博泰2023年营收大增九成亏损收窄
时代周报 · 03-27 14:42
默沙东去年打款超14亿元 科伦博泰2023年营收大增九成亏损收窄
默沙东(MRK.US)“first-in-class”疗法获FDA批准
智通财经 · 03-27 08:44
默沙东(MRK.US)“first-in-class”疗法获FDA批准
默沙东(MRK.US)盘后涨近5%!旗下肺动脉高压药物sotatercept获FDA批准
智通财经 · 03-27 07:40
默沙东(MRK.US)盘后涨近5%!旗下肺动脉高压药物sotatercept获FDA批准
潜在重磅!默沙东“first-in-class”疗法获FDA批准
药明康德 · 03-27 06:21
潜在重磅!默沙东“first-in-class”疗法获FDA批准
BUZZ-美国 FDA 批准血压疗法后,默克涨势喜人
Reuters · 03-27 05:30
BUZZ-美国 FDA 批准血压疗法后,默克涨势喜人
美国 FDA 批准默克公司的血压疗法
Reuters · 03-27 05:06
美国 FDA 批准默克公司的血压疗法
受益于默沙东合作项目 科伦博泰去年营收同比增九成
每日经济新闻 · 03-26
受益于默沙东合作项目 科伦博泰去年营收同比增九成
默沙东上涨1.33%,报125.5美元/股
金融界 · 03-25
默沙东上涨1.33%,报125.5美元/股
加载更多
公司概况
公司名称:
默沙东
所属市场:
NYSE
上市日期:
--
主营业务:
默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。
发行价格:
--
{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":131.95,"timestamp":1711656000000,"preClose":131.75,"halted":0,"volume":10189650,"hourTrading":{"tag":"盘后","latestPrice":131.95,"preClose":131.95,"latestTime":"19:57 EDT","volume":1411729,"amount":186276909.681,"timestamp":1711670271052},"delay":0,"floatShares":2527821718,"shares":2532643872,"eps":0.14,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":0.2,"latestTime":"03-28 16:00:00 EDT","open":132,"high":132.42,"low":131.08,"amount":1343138321.307,"amplitude":0.010171,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.14,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":0,"listingDate":-745790400000,"adjPreClose":131.75,"adrRate":0,"dividendRate":0.02213,"preHourTrading":{"tag":"盘前","latestPrice":132.05,"preClose":131.75,"latestTime":"09:29 EDT","volume":30716,"amount":4083750.5604,"timestamp":1711632599092},"postHourTrading":{"tag":"盘后","latestPrice":131.95,"preClose":131.95,"latestTime":"19:57 EDT","volume":1411729,"amount":186276909.681,"timestamp":1711670271052},"volumeRatio":1.0691219310045457},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"2423040131","title":"重磅新药获批 默沙东股价再创历史新高丨从华尔街到陆家嘴","url":"https://stock-news.laohu8.com/highlight/detail?id=2423040131","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2423040131?lang=zh_cn&edition=full","pubTime":"2024-03-29 10:31","pubTimestamp":1711679510,"startTime":"0","endTime":"0","summary":"重磅新药获批,默沙东股价再创历史新高。Winrevair对肺动脉高压症(PAH)患者的预期年销售额达到50亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202403293029245064.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403293029245064.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422199685","title":"默沙东甲肝疫苗即将退出中国","url":"https://stock-news.laohu8.com/highlight/detail?id=2422199685","media":"健识局","top":-1,"share":"https://www.laohu8.com/m/news/2422199685?lang=zh_cn&edition=full","pubTime":"2024-03-28 20:56","pubTimestamp":1711630560,"startTime":"0","endTime":"0","summary":"据界面新闻3月27日报道,默沙东旗下的甲肝疫苗即将停止在中国市场的供应。在“默沙东甲肝疫苗退市”消息流出之前,有媒体曾披露这款疫苗在国内多地已经大面积缺货,近年来在国内的签发数量也逐年减少。根据默沙东2023年财报,公司在疫苗领域共布局9大产品,其中宫颈癌疫苗和水痘疫苗系列销售最好,2023年共卖出113亿美元,而甲肝疫苗总营收最低,去年销售额仅1.2亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032820565987c0c744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032820565987c0c744&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422160765","title":"默沙东重磅新药在美获批 定价14000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422160765","media":"国际金融报","top":-1,"share":"https://www.laohu8.com/m/news/2422160765?lang=zh_cn&edition=full","pubTime":"2024-03-28 20:14","pubTimestamp":1711628063,"startTime":"0","endTime":"0","summary":"美国东部时间3月26日,默沙东宣布其用于治疗动脉性肺动脉高压(PAH)新药Winrevair获美国食品药品监督管理局(FDA)批准。消息一出,默沙东股价狂飙。截止当地时间3月27日美股收盘,默沙东每股报价131.75美元,涨幅近5%,创历史新高,总市值达3337亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202403283028142546.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403283028142546.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422799469","title":"重磅新药获批,1瓶10万!股价狂飙,影响多大?","url":"https://stock-news.laohu8.com/highlight/detail?id=2422799469","media":"券商中国","top":-1,"share":"https://www.laohu8.com/m/news/2422799469?lang=zh_cn&edition=full","pubTime":"2024-03-28 09:10","pubTimestamp":1711588259,"startTime":"0","endTime":"0","summary":"据估计,2021年全球约4000万例PAH患者,5年内的死亡率约为43%。目前,有11款用于治疗PAH药物已获批上市,已上市的11款药物可通过促进肺血管扩张来缓解患者病情,但无法从根本上解决肺血管重塑的问题。该药物每三周注射一次,以单瓶或双瓶试剂盒形式分发。对于高昂的费用,默沙东表示,由于服用剂量根据体重计算,因此费用会因病人而异。文章来源:券商中国文章作者:周乐重磅新药获批,1瓶10万!股价狂飙,影响多大?","market":"us","thumbnail":"https://static.tigerbbs.com/fcc6dde1ecddaa17fe78079bc1ee0d48","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fcc6dde1ecddaa17fe78079bc1ee0d48"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280749277a4f96f7&s=b","is_publish_highlight":true,"gpt_icon":1},{"id":"2422764329","title":"隔夜美股全复盘(3.28)| 三大股指集体收涨,DJT涨逾14%,华尔街对特朗普科技集团估值达到110亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2422764329","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2422764329?lang=zh_cn&edition=full","pubTime":"2024-03-28 07:39","pubTimestamp":1711582798,"startTime":"0","endTime":"0","summary":"三大股指集体收涨,DJT涨逾14%,华尔街对特朗普科技集团估值达到110亿预期","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/712968","is_publish_highlight":false,"gpt_icon":0},{"id":"2422992453","title":"美股三大指数集体高开 默沙东涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422992453","media":"证券时报e公司","top":-1,"share":"https://www.laohu8.com/m/news/2422992453?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:35","pubTimestamp":1711546500,"startTime":"0","endTime":"0","summary":"转自:证券时报·e公司\n\n e公司讯,美股三大指数集体高开,道指涨0.59%,纳指涨0.67%,标普500指数涨0.59%。默沙东涨近6%,肺动脉高压药物sotatercept获FDA批准。游戏驿站跌超15%,四季度业绩不及预期。 \n\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-03-27/doc-inapusen6331770.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-03-27/doc-inapusen6331770.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422992419","title":"默沙东盘中异动 股价大涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422992419","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422992419?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:34","pubTimestamp":1711546440,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时34分,默沙东股票出现波动,股价大幅拉升5.85%。默沙东股票所在的制药行业中,整体涨幅为1.18%。此外,默沙东还销售与动物健康相关的药物。消息层面,截至21时34分,默沙东股票正面舆情新闻比例30.77%。该信息摘要如下:2023年,依靠从默沙东处获得的管线授权首付款及里程碑付款,科伦博泰营收同比涨超90%,亏损收窄6.8%。3月25日晚间,科伦博泰发布了上市以来的首份年报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272134028b69dbbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272134028b69dbbc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422861990","title":"国产九价HPV疫苗有望今年上市 市场格局或生变","url":"https://stock-news.laohu8.com/highlight/detail?id=2422861990","media":"新京报网","top":-1,"share":"https://www.laohu8.com/m/news/2422861990?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:34","pubTimestamp":1711546440,"startTime":"0","endTime":"0","summary":"按照常规流程推算,公司九价HPV疫苗有望在今年获批。2018年4月28日,默沙东九价HPV疫苗也获批进入国内市场。很快,二价HPV疫苗迎来了国产入局者。进口九价HPV疫苗的接种次数也在减少。剩余市场空间取决于接种率默沙东九价HPV疫苗的关键专利将于2025年到期,在国产九价HPV疫苗上市之前,接种率成为决定剩余市场空间的关键。目前国内尚未将HPV疫苗纳入免疫规划,市场增长速度和空间规模势必会受到影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327213600791d4b60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327213600791d4b60&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422918577","title":"《美国股市》道指早段飙逾300点跑出 默克新药获批股价飙5% 英伟达逆市跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2422918577","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422918577?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:31","pubTimestamp":1711546260,"startTime":"0","endTime":"0","summary":"美股一反连跌多日的走势反弹,道指高开179.65点或0.46%后,越升越有,道指早段飙升逾300点。默克获美国食品药物管理局批准其Winrevair新药推出,该药用于治疗肺动脉高压患者的危及生命的肺部疾病治疗药物,该股飙升5%,创52周新高。纳指则高开109.06点或0.67%,报16,424.76点。英伟达逆市倒跌0.9%。蔚来美股开盘跌近6%,公司先前下调首季交付预期,预计第一季交付量为3万辆。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180124172319542_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180124172319542_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337824/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422663599","title":"默沙东进口甲肝疫苗将退出国内市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2422663599","media":"南方财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422663599?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:06","pubTimestamp":1711534005,"startTime":"0","endTime":"0","summary":"南方财经3月27日电,记者日前从多个消息源处获,悉默沙东即将停止其甲肝疫苗维康特®在国内市场的供应。3月27日,默沙东中国方面确认,默沙东基于全球商业策略的调整、现有研发与生产资源的谨慎评估以及对本土产品可满足市场需求的充分考量,现做出业务调整决策,决定即日起不再向中国市场供应维康特®。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403273026310320.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422963618","title":"BUZZ-默克公司因美国食品药品管理局批准罕见肺病疗法而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2422963618","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422963618?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:55","pubTimestamp":1711533331,"startTime":"0","endTime":"0","summary":" 3月27日 - ** 默克 股价盘前上涨5%至131.3美元 ** 美国食品和药物管理局批准默克公司治疗罕见肺病的药物 ** 名为Winrevair的疗法将用于治疗因肺动脉收缩而导致的成人高血压 - MRK** Winrevair的上市价格为每瓶14,000美元,大多数患者每三周使用一瓶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422959488","title":"默沙东盘前涨超4%势创新高 肺动脉高压药物sotatercept获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2422959488","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422959488?lang=zh_cn&edition=full","pubTime":"2024-03-27 16:17","pubTimestamp":1711527428,"startTime":"0","endTime":"0","summary":"默沙东美股盘前涨4.37%,报131.01美元,开盘后股价势将创下历史新高。消息面上,美国食品药品管理局批准了默沙东旗下用于治疗肺动脉高压的sotatercept,该药品后续将被命名为Winrevair。据悉,在没有保险的情况下,该药物每瓶售价为1.4万美元,绝大多数患者每三周服用一瓶,即每年需花费大约24.2万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032716254387bb7b73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032716254387bb7b73&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422934154","title":"默沙东去年打款超14亿元 科伦博泰2023年营收大增九成亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2422934154","media":"时代周报","top":-1,"share":"https://www.laohu8.com/m/news/2422934154?lang=zh_cn&edition=full","pubTime":"2024-03-27 14:42","pubTimestamp":1711521743,"startTime":"0","endTime":"0","summary":"3月25日晚,ADC(抗体药物偶联物)龙头科伦博泰生物(06990.HK)公布了2023年财务数据,数据显示,公司全年收入15.4亿元,同比增长91.6%;年度亏损达5.74亿元,同比下降6.8%;调整后年度亏损为4.51亿元,同比下降24.4%。此外,科伦博泰经营活动现金流量由负转正。截止2023年12月31日,公司现金及金融资产约为25.3亿元,去年同期为1.19亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403273026048324.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422431603","title":"默沙东(MRK.US)“first-in-class”疗法获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2422431603","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422431603?lang=zh_cn&edition=full","pubTime":"2024-03-27 08:44","pubTimestamp":1711500294,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3月27日,FDA官方网站显示已批准默沙东的“first-in-class”疗法Winrevair上市,用于治疗肺动脉高压。信息显示,它具有成为治疗肺动脉高压的基石性疗法的潜力。据了解,Sotatercept是一款“first-in-class”的IIA型激活素受体融合蛋白。Sotatercept是默沙东于2021年以约115亿美元收购Acceleron Pharma公司获得的关键疗法。此前,sotatercept已获得FDA授予的突破性疗法认定,这也是首款获得突破性疗法认定的肺动脉高压疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1093078.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422674723","title":"默沙东(MRK.US)盘后涨近5%!旗下肺动脉高压药物sotatercept获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2422674723","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422674723?lang=zh_cn&edition=full","pubTime":"2024-03-27 07:40","pubTimestamp":1711496443,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,美国食品药品管理局批准了默沙东旗下用于治疗肺动脉高压的sotatercept,该药品后续将被命名为Winrevair。受此消息提振,截至发稿,默沙东周二美股盘后涨近5%。据悉,默沙东在2021年斥资115亿美元收购Acceleron Pharma的交易中获得了在研疗法sotatercept。此外,受默沙东旗下sotatercept获批影响,美国联合医疗周二美股盘后跌超5%,原因是sotatercept获批可能会对美国联合医疗旗下同样用于治疗肺动脉高压的Tyvaso和Remodulin的销售造成影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1093043.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422835671","title":"潜在重磅!默沙东“first-in-class”疗法获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2422835671","media":"药明康德","top":-1,"share":"https://www.laohu8.com/m/news/2422835671?lang=zh_cn&edition=full","pubTime":"2024-03-27 06:21","pubTimestamp":1711491676,"startTime":"0","endTime":"0","summary":"刚刚,FDA官方网站显示已批准默沙东的“first-in-class”疗法Winrevair上市,用于治疗肺动脉高压。▲Sotatercept调整促进和抑制增生信号的平衡Sotatercept是一款“first-in-class”的IIA型激活素受体融合蛋白。Sotatercept是默沙东于2021年以约115亿美元收购Acceleron Pharma公司获得的关键疗法。此前,sotatercept已获得FDA授予的突破性疗法认定,这也是首款获得突破性疗法认定的肺动脉高压疗法。2023年3月,默沙东公布了该关键性3期临床试验完整结果。在sotatercept之后,默沙东又一款PAH疗法也已步入了2/3期临床试验阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032706223687b956bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032706223687b956bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422678319","title":"BUZZ-美国 FDA 批准血压疗法后,默克涨势喜人","url":"https://stock-news.laohu8.com/highlight/detail?id=2422678319","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422678319?lang=zh_cn&edition=full","pubTime":"2024-03-27 05:30","pubTimestamp":1711488603,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 3月26日 - ** 默克公司股价 上涨4.5%,报131.06美元。** 美国食品和药物管理局(FDA)批准了 (link) 公司的新疗法 Winrevair,用于治疗成人肺动脉高压患者。** 默克公司美国人类健康业务总裁 Jannie Oosthuizen 告诉路透社,Winrevair 的上市价格为每瓶 14,000 美元。** 根据共同试验的数据,大多数患者将每三周使用一小瓶,折合每年 23.8 万美元。** MRK预计能在4月底将该药推向市场。** 股价已累计上涨 15.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422620840","title":"美国 FDA 批准默克公司的血压疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2422620840","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422620840?lang=zh_cn&edition=full","pubTime":"2024-03-27 05:06","pubTimestamp":1711487161,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透社3月26日 - 美国食品和药物管理局(FDA)周二批准了默克公司的 治疗肺动脉收缩引起的成人高血压的药物,为这家制药巨头的产品组合增添了又一种潜在的大片药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422668466","title":"受益于默沙东合作项目 科伦博泰去年营收同比增九成","url":"https://stock-news.laohu8.com/highlight/detail?id=2422668466","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2422668466?lang=zh_cn&edition=full","pubTime":"2024-03-26 16:56","pubTimestamp":1711443389,"startTime":"0","endTime":"0","summary":"3月25日晚,科伦博泰生物-B(HK6990,股价160.6港元,市值352亿港元)公布了2023年业绩。得益于此前与默沙东达成的授权合作收入,科伦博泰去年同比减亏6.8%;营业收入同比增长超9成,取得收入15.40亿元。根据科伦博泰此前与默沙东订立的合作协议,二者合作给科伦博泰带来的预付款及里程碑付款总额可高达118亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202403263024504876.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403263024504876.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422548505","title":"默沙东上涨1.33%,报125.5美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422548505","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422548505?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:41","pubTimestamp":1711374116,"startTime":"0","endTime":"0","summary":"3月25日,默沙东(MRK)盘中上涨1.33%,截至21:41,报125.5美元/股,成交5135.12万美元。财务数据显示,截至2023年12月31日,默沙东收入总额601.15亿美元,同比增长1.4%;归母净利润3.65亿美元,同比减少97.49%。大事提醒:4月25日,默沙东将于(美东)盘前披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/03/25214139985859.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":0.0674},{"period":"1month","weight":0.0226},{"period":"3month","weight":0.2103},{"period":"6month","weight":0.2817},{"period":"1year","weight":0.2576},{"period":"ytd","weight":0.2103}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.568182,"avgChangeRate":0.009892},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.000396},{"month":3,"riseRate":0.636364,"avgChangeRate":-0.002321},{"month":4,"riseRate":0.636364,"avgChangeRate":0.019488},{"month":5,"riseRate":0.659091,"avgChangeRate":0.019791},{"month":6,"riseRate":0.522727,"avgChangeRate":0.013252},{"month":7,"riseRate":0.5,"avgChangeRate":0.00548},{"month":8,"riseRate":0.477273,"avgChangeRate":0.000646},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.005533},{"month":10,"riseRate":0.545455,"avgChangeRate":0.021263},{"month":11,"riseRate":0.727273,"avgChangeRate":0.029373},{"month":12,"riseRate":0.613636,"avgChangeRate":0.014794}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}